Literature DB >> 29892518

Pathways to Neuroprediction: Opportunities and challenges to prediction of treatment response in depression.

Scott A Langenecker1, Natania A Crane1, Lisanne M Jenkins1, K Luan Phan1, Heide Klumpp1.   

Abstract

PURPOSE OF REVIEW: We set out to review the current state of science in neuroprediction, using biological measures of brain function, with task based fMRI to prospectively predict response to a variety of treatments. RECENT
FINDINGS: Task-based fMRI neuroprediction studies are balanced between whole brain and ROI specific analyses. The predominant tasks are emotion processing, with ROIs based upon amygdala and subgenual anterior cingulate gyrus, both within the salience and emotion network. A rapidly emerging new area of neuroprediction is of disease course and illness recurrence. Concerns include use of open-label and single arm studies, lack of consideration of placebo effects, unbalanced adjustments for multiple comparisons (over focus on type I error), small sample sizes, unreported effect sizes, overreliance on ROI studies.
SUMMARY: There is a need to adjust neuroprediction study reporting so that greater coherence can facilitate meta analyses, and increased funding for more multiarm studies in neuroprediction.

Entities:  

Keywords:  Depression; cognitive behavioral therapy; fMRI; networks; prediction; psychopharmacology

Year:  2018        PMID: 29892518      PMCID: PMC5992916     

Source DB:  PubMed          Journal:  Curr Behav Neurosci Rep


  73 in total

1.  The course, morbidity, and costs of depression.

Authors:  G L Klerman; M M Weissman
Journal:  Arch Gen Psychiatry       Date:  1992-10

Review 2.  Frontocingulate dysfunction in depression: toward biomarkers of treatment response.

Authors:  Diego A Pizzagalli
Journal:  Neuropsychopharmacology       Date:  2010-09-22       Impact factor: 7.853

3.  Neural correlates of sad faces predict clinical remission to cognitive behavioural therapy in depression.

Authors:  Sergi G Costafreda; Akash Khanna; Janaina Mourao-Miranda; Cynthia H Y Fu
Journal:  Neuroreport       Date:  2009-05-06       Impact factor: 1.837

Review 4.  A systematic review of relations between resting-state functional-MRI and treatment response in major depressive disorder.

Authors:  Gabriel S Dichter; Devin Gibbs; Moria J Smoski
Journal:  J Affect Disord       Date:  2014-09-26       Impact factor: 4.839

5.  Identification of Common Neural Circuit Disruptions in Cognitive Control Across Psychiatric Disorders.

Authors:  Lisa M McTeague; Julia Huemer; David M Carreon; Ying Jiang; Simon B Eickhoff; Amit Etkin
Journal:  Am J Psychiatry       Date:  2017-03-21       Impact factor: 18.112

6.  Neural correlates of emotional processing in depression: changes with cognitive behavioral therapy and predictors of treatment response.

Authors:  Maureen Ritchey; Florin Dolcos; Kari M Eddington; Timothy J Strauman; Roberto Cabeza
Journal:  J Psychiatr Res       Date:  2010-10-12       Impact factor: 4.791

7.  Effects of duloxetine treatment on brain response to painful stimulation in major depressive disorder.

Authors:  Marina López-Solà; Jesus Pujol; Rosa Hernández-Ribas; Ben J Harrison; Oren Contreras-Rodríguez; Carles Soriano-Mas; Joan Deus; Héctor Ortiz; José M Menchón; Julio Vallejo; Narcís Cardoner
Journal:  Neuropsychopharmacology       Date:  2010-07-28       Impact factor: 7.853

8.  Effect sizes for growth-modeling analysis for controlled clinical trials in the same metric as for classical analysis.

Authors:  Alan Feingold
Journal:  Psychol Methods       Date:  2009-03

9.  Sustained anterior cingulate cortex activation during reward processing predicts response to psychotherapy in major depressive disorder.

Authors:  Hannah Carl; Erin Walsh; Tory Eisenlohr-Moul; Jared Minkel; Andrew Crowther; Tyler Moore; Devin Gibbs; Chris Petty; Josh Bizzell; Gabriel S Dichter; Moria J Smoski
Journal:  J Affect Disord       Date:  2016-06-04       Impact factor: 4.839

10.  Cellular mechanisms underlying the antidepressant effects of ketamine: role of alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid receptors.

Authors:  Sungho Maeng; Carlos A Zarate; Jing Du; Robert J Schloesser; Joseph McCammon; Guang Chen; Husseini K Manji
Journal:  Biol Psychiatry       Date:  2007-07-23       Impact factor: 13.382

View more
  3 in total

1.  An Examination of Motivation to Change and Neural Alcohol Cue Reactivity Following a Brief Intervention.

Authors:  Erica N Grodin; Aaron C Lim; James MacKillop; Mitchell P Karno; Lara A Ray
Journal:  Front Psychiatry       Date:  2019-06-11       Impact factor: 4.157

2.  SSRI Treatment Response Prediction in Depression Based on Brain Activation by Emotional Stimuli.

Authors:  Antonia Preuss; Bianca Bolliger; Wenzel Schicho; Josef Hättenschwiler; Erich Seifritz; Annette Beatrix Brühl; Uwe Herwig
Journal:  Front Psychiatry       Date:  2020-11-13       Impact factor: 4.157

3.  Predicting Antidepressant Citalopram Treatment Response via Changes in Brain Functional Connectivity After Acute Intravenous Challenge.

Authors:  Manfred Klöbl; Gregor Gryglewski; Lucas Rischka; Godber Mathis Godbersen; Jakob Unterholzner; Murray Bruce Reed; Paul Michenthaler; Thomas Vanicek; Edda Winkler-Pjrek; Andreas Hahn; Siegfried Kasper; Rupert Lanzenberger
Journal:  Front Comput Neurosci       Date:  2020-10-06       Impact factor: 2.380

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.